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Proteomics and Metabolite Analysis Reveals the Role of hnRNP K in HK2
Cells
L. Q. H. He, Z. J. W. Wang, Q. S. Sun, Z. M. T. Tian
The Key Laboratory of Biomedical Information Engineering of Ministry of
Education, School of Life Science and Technology, Xi’an Jiaotong University,
Xi’an, China
Background: Salt sensitive hypertension is a kind of metabolic syndrome.
hnRNP K was up-regulated in renal medulla of salt resistant rats, but
down-regulated in salt sensitive rats and the latter developed hypertension.
The function of hnRNP K in renal cells of salt sensitive hypertension rats is
not fully understood.
Methods: Proteomics and metabolomics profiling, Western blot, biochem-
istry analysis and ATP generation rate detection were used to figure out
the globe regulatory functions of hnRNP K in HK2 cells through siRNA knock-
down technology.
Results: The proteomics analysis indicated that the expression of multiple en-
zymes inmitochondrial were increasedwhile hnRNPKwas knockeddown, such
as MDH, PDH ,ɑ-KGDH, NADH dehydrogenase, cytochrome b-c1 complex, cyto-
chrome c and ATP synthase, of which, MDH, PDH , cytochrome c were further
verified by western blot. The activities of MDH, FH, ɑ-KGDH and mitochondria
NADP-ICDwere also increased. Boinformatic analysis revealed that glycolysis/
gluconeogenesis was decreased and TCA and oxidative phosphorylation
pathway were significantly increased. The results suggested that the function
of mitochondrial improved, which were confirmed by the increasing of mem-
brane potential and ATP generation rate when hnRNP K was knocked down.
Further detection of metabolic intermediates by GC/MS showed succinate,
malate, lactate acid, 11 amino acids which could transform to substrates of
TCAwere decreased in hnRNP K knockdown cells except pyruvate. The change
of metabolic compounds confirmed the results of bioinformatic analysis.
Conclusion: Consequently, current research work demonstrated that down-
regulated hnRNP K contributes to enhanced protein expression of the TCA
cycle and oxidative phosphorylation, but depresses glycolysis/gluconeogen-
esis in kidney cells. These data also suggested that the regulatory function of
hnRNP K to metabolism of mitochondrial could be involved in the develop-
ment of salt induced hypertension.http://dx.doi.org/10.1016/j.hkjn.2015.08.0750117
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Objective: The aim of the present study was to investigate the prevalence,
awareness, treatment, and control of hypertension in the non-dialysis CKD
patients through a nationwide, multicenter study in China.
Methods: The survey was performed in 61 tertiary hospitals in 31 provinces,
municipalities, and autonomous regions in China (except Hong Kong, Macao,
and Taiwan). Trained physicians collected demographic and clinical data and
measured blood pressure (BP) using a standardized protocol. Antihyperten-
sive drugs were classified into a single category and the percent of every
category were counted. Resistant hypertension was defined as BP above
the target BP (< 140/90 mmHg) despite the use of 3 antihypertensive drugs
or achieving the target BP by using  4 antihypertensive drugs.
Results: The analysis included 8927 non-dialysis CKD patients. The preva-
lence, awareness, and treatment of hypertension in non-dialysis CKD pa-
tients were 67.3%, 85.8%, and 81.0%, respectively. Of hypertensive CKD
patients, 33.1% had controlled BP to < 140/90 mmHg. In 4435 participants
who had records of antihypertensive treatment, 36.9% achieved hyperten-
sion control, 11.1% met the criteria for resistant hypertension and 52.0%
used  2 antihypertensive drugs and were uncontrolled.
Conclusion: The prevalence of hypertension Chinese non-dialysis CKD patients
was high, and the hypertension control was suboptimal. Compared to resistant
hypertension, the inadequate use of antihypertensive drugs appeared to
contribute more to the lack of hypertension control in CKD patients.http://dx.doi.org/10.1016/j.hkjn.2015.08.0760205
Role of Mitochondrial Dysfunction and ROS Production in Ang II-induced
NLRP3 Inflammasome Activation
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Objective: The type 1 angiotensin (AT1) receptor plays an important role in
maintaining blood pressure. Previous studies suggested that the activation of
immune responses by angiotensin (Ang) II during hypertension may aggravate
renal damage. NLRP3 inflammasome activation promotes renal inflammation
and contributes to chronic kidney damage. Further investigation should be
performed to explore the correlation between the RAS and NLRP3 inflamma-
some activation, and possible mechanisms.
Methods: C57BL/6 AT1R-/- and NLRP3-/- mice underwent left nephrectomy
followed 1 week for recovery. Blood pressure measurements were recorded
at baseline and following 4 weeks of chronic Ang II or saline infusion. At the
end of the experiment, the kidney were harvested and fixed. AT1R siRNA and
mitoTEMPO treatment were performed before the Ang II stimulation in HK2
cells. The expression levels of NLRP3 inflammasome and mitochondrial
dysfunction were measured.
Results: Ang II significantly induced kidney injury and NLRP3 inflammasome
activation. Mitochondria swelling and fragmentation were observed by trans-
mission electron microscope. AT1-/- blocked Ang II-induced hypertension,
inhibiting the mitochondrial dysfunction and NLRP3 expression. Deficiency
of NLRP3 attenuated kidney injury in hypertension with no significant influ-
ence to blood pressure. In vitro studies showed that Ang II stimulation in-
crease the mitochondrial damage and NLRP3 activation in dose- and time-
